Seeking Alpha

  Intercept Pharmaceuticals - NASDAQ

11/28/2014, 1:58 AM ET
  • MD Research | Send Message 31 Jan

    Intercept Pharmaceuticals: Elucidating The Ramifications The For Flint Trial $ICPT
      ICPT vs. ETF Alternatives
      Company Description
      Intercept Pharmaceuticals Inc is a development stage, Biopharmaceutical Company engaged in the development and commercialization of novel therapeutics to treat chronic liver disease utilizing its proprietary bile acid chemistry.
      Sector: Healthcare
      Industry: Biotechnology
      Country: United States